Salvage chemotherapy for lymphoma with V
โ
Nichols, Craig R. ;Loehrer, Patrick J. ;Greist, Anne ;Kubilis, Paul S. ;Hoffman,
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 425 KB
Between 1983 and 1985, we conducted a phase I I clinical trial using VP-16, ifosfamide, and cisplatin (VIP) in patients with refractory lymphoma. Twentyeight patients with bidimensional measurable disease were treated with VP-16 (75 mg/m2), ifosfamide (1.2 g/m2), and cisplatin (20 mg/m2) as daily in